Drug Execs Face Capitol Hill Questions on Vaccine Supply

The companies insist they will be able to provide enough for most Americans by summer.

  • Published
FILE - In this Feb. 12, 2021, file photo, scripps health official draws from a vile of the COVID-19 vaccine prior to administering it at their new drive-thru vaccination site at the Del Mar Fairgrounds in Del Mar, Calif. Executives from the major COVID-19 vaccine producers are set Tuesday, Feb. 23, to answer questions from Congress about expanding the supply of shots needed to curb the pandemic that has killed more than 500,000 Americans. (Nelvin C. Cepeda/The San Diego Union-Tribune via AP, Pool, File)
Image via AP Photo/Nelvin C. Cepeda

This article was republished here with permission from The Associated Press, however it is no longer available to read on Snopes.com.

WASHINGTON (AP) — COVID-19 vaccine makers told Congress on Tuesday to expect a big jump in the delivery of doses over the coming month after a rocky start to inoculations, and the companies insist they will be able to provide enough for most Americans by summer. By the end of March, Pfizer and Moderna expect to have provided the U.S. government with a total of 220 million vaccine doses, up from the roughly 75 million…

Read at AP News